Change in Faron’s Management Team
Faron Pharmaceuticals Ltd. (“Faron” or the “Company”) Change in Faron’s Management Team Company announcement, December 1, 2021 at 02:00 AM (EDT) / 07:00 AM (GMT) / 09:00 AM (EET) TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announced that Chief Medical Officer (“CMO”), Dr. Matti Karvonen, will leave the Company as of December 1, 2021. The Company